Related Experiment Video
Updated: Mar 8, 2026
09:51
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
13.1K
TLR9 and its signaling pathway in multiple sclerosis
Yifan Zhou1, Ling Fang1, Lisheng Peng1
1Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Journal of the Neurological Sciences
|January 30, 2017
Summary
Multiple sclerosis (MS) involves central nervous system damage. This study explores the role of Toll-like receptor 9 (TLR9) in MS pathogenesis and potential therapies.
Area of Science:
- Neuroimmunology
- Innate Immunity
Background:
- Multiple sclerosis (MS) is a chronic autoimmune central nervous system disease.
- While T cells are implicated, the innate immune system's role, particularly Toll-like receptors (TLRs), is increasingly recognized.
- TLR9, a nucleic acid sensor, is a key focus in understanding MS etiology.
Purpose of the Study:
- To discuss the role of TLR9 and its signaling pathway in multiple sclerosis development.
- To present potential therapeutic strategies targeting TLR9 based on current research.
Main Methods:
- Review of existing literature on TLR9 and MS.
- Analysis of in vivo and in vitro findings related to TLR9 signaling in MS.
Main Results:
- TLR9 activation and its signaling pathways are involved in MS pathogenesis.
- Targeting TLR9 presents a promising therapeutic avenue for MS.
Conclusions:
- TLR9 plays a significant role in the immunopathogenesis of multiple sclerosis.
- Therapeutic strategies modulating TLR9 signaling warrant further investigation for MS treatment.
Related Concept Videos
01:24T Cell Types and Functions
3.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K
01:16TGF - β Signaling Pathway
10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
01:00Enzyme-linked Receptors
88.0K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
88.0K